Tag Archives: High

Genentech Announces FDA Approval of Xofluza (baloxavir marboxil) for People at High Risk of Developing Influenza-Related Complications

Print this page South San Francisco, CA — October 17, 2019 — Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of… Read More »

High schoolers who don’t date are less depressed than their counterparts who do, study says

But a recent study published in the Journal of School Health reveals that adolescents who choose not to date fare as well as, or better than, their coupled counterparts in social and leadership skills. They’re also less depressed. “We know that romantic relationships are very common among adolescents — in fact, a majority have been… Read More »